Skip to main navigation

Back

Contact Revance
Login

Menu

Aesthetics
Back Aesthetics
Visit Site
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

All News
Company
Back Company
OUR LATEST
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

1222 Demonbreun St
20th Floor
Nashville, TN 37203

+1 (510) 742-3400

Contact Revance
Login

© Copyright 2021

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

November 19, 2015

Revance Therapeutics to Participate in the 27th Annual Piper Jaffray Healthcare Conference

November 9, 2015

Revance Therapeutics Releases Third Quarter 2015 Results

November 9, 2015

Revance Therapeutics Announces Closing of Public Offering of Common Stock

November 4, 2015

Revance Therapeutics to Present at Credit Suisse 24th Annual Healthcare Conference

November 4, 2015

Revance Therapeutics to Release Third Quarter 2015 Financial Results Monday, November 9, 2015

November 4, 2015

Revance Therapeutics Announces Pricing of Public Offering of Common Stock

November 2, 2015

Revance Therapeutics Announces Proposed Public Offering of Common Stock

October 29, 2015

Revance Reports Positive 6-Month Duration in BELMONT Study

September 29, 2015

Revance Therapeutics Initiates Phase 2 Clinical Study of Its Unique Botulinum Toxin Type A for Injection to Treat Cervical Dystonia

September 28, 2015

Revance Therapeutics Initiates Phase 3 Clinical Trial of Botulinum Toxin Type A Topical Gel to Treat Lateral Canthal Lines

Pagination

First page
Previous page
…
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
…
Next page
Last page

Displaying 201 - 210 of 261

Investor Relations

Investor Relations
Press Releases
Events & Presentations
- Events
- Presentations and Corporate Materials
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

1222 Demonbreun St
20th Floor
Nashville, TN 37203

+1 (510) 742-3400

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
OPUL
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Cervical Dystonia
Upper Limb Spasticity
Plantar Fasciitis
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ
Contact Us

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Investigator Sponsored Trials
Medical Education Grants
Sustainability
Contact Revance

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks

© Copyright 2021
All Rights Reserved
Terms of Use
Privacy Policy
Corporate Social Media Community Guidelines

Facebook
LinkedIn